| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2011 | Il-28b predicts response to chronic hepatitis C therapy -fine-mapping and replication study in Asian populations | Ochi H.; Maekawa T.; Abe H.; Hayashida Y.; Nakano R.; Imamura M.; Hiraga N.; Kawakami Y.; Aimitsu S.; JIA-HORNG KAO ; Tsunoda M.K.; Tsunoda T.; Kumada H.; Nakamura Y.; Hayes N.C.; Chayama K. | Journal of General Virology | 51 | 42 | |
| 2016 | Peginterferon Lambda-1a/ribavirin with daclatasvir or peginterferon alfa-2a/ribavirin with telaprevir for chronic hepatitis c genotype 1b | Flisiak R.; Kawazoe S.; Znoyko O.; Assy N.; Gadano A.; JIA-HORNG KAO ; Lee K.-S.; Zwirtes R.; Portsmouth S.; Dong Y.; Xu D.; Kumada H.; Srinivasan S. | Journal of Interferon and Cytokine Research | 10 | 9 | |
| 2021 | Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT | Okusaka T.; Ikeda K.; Kudo M.; Finn R.; Qin S.; Han K.-H.; ANN-LII CHENG ; Piscaglia F.; Kobayashi M.; Sung M.; Chen M.; Wyrwicz L.; Yoon J.-H.; Ren Z.; Mody K.; Dutcus C.; Tamai T.; Ren M.; Hayato S.; Kumada H. | Journal of Gastroenterology | 7 | 7 |
